EDGAR Filing Documents for 0001387131-23-012417

Form 8-K - Current report:

SEC Accession No. 0001387131-23-012417

Filing Date

2023-10-19

Accepted

2023-10-19 17:07:43

Documents

Period of Report

2023-10-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	dmk-8k_101623.htm iXBRL	8-K	51867
2	EMPLOYMENT AGREEMENT	ex10-1.htm	EX-10.1	122820
3	EMPLOYMENT AGREEMENT	ex10-2.htm	EX-10.2	103881
4	INDUCEMENT STOCK OPTION AWARD AGREEMENT	ex10-3.htm	EX-10.3	152311
5	FORM OF INDUCEMENT STOCK OPTION AWARD AGREEMENT	ex10-4.htm	EX-10.4	160967
	Complete submission text file	0001387131-23-012417.txt		898928

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	dmk-20231016.xsd	EX-101.SCH	3051
7	XBRL LABEL FILE	dmk-20231016_lab.xml	EX-101.LAB	34240
8	XBRL PRESENTATION FILE	dmk-20231016_pre.xml	EX-101.PRE	22384
10	EXTRACTED XBRL INSTANCE DOCUMENT	dmk-8k_101623_htm.xml	XML	3296

Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130

Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400

DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)